Designing potent inhibitors against the multidrug resistance P-glycoprotein

Reference

• Adams, M. J. (1995). Chemometrics in analytical spectroscopy (2nd ed.). (Royal Soci; R. S. of Chemistry, Ed.). Retrieved from https://doi.org/10.1039/9781847550484
   Google Scholar
• Ahmed, S., Islam, N., Shahinozzaman, M., Fakayode, S. O., Afrin, N., & Halim, M. A. (2021). Virtual screening, molecular dynamics, density functional theory and quantitative structure activity relationship studies to design peroxisome proliferator-activated receptor-γ agonists as anti-diabetic drugs. Journal of Biomolecular Structure & Dynamics, 39(2), 728–715. https://doi.org/10.1080/07391102.2020.1714482
   PubMed Web of Science ®Google Scholar
• Alam, S., & Khan, F. (2017). 3D-QSAR studies on maslinic acid analogs for anticancer activity against breast cancer cell line MCF-7. Scientific Reports, 7(1), 1–13. https://doi.org/10.1038/s41598-017-06131-0
   PubMedGoogle Scholar
• Aller, S. G., Yu, J., Ward, A., Weng, Y., Chittaboina, S., Zhuo, R., Harrell, P. M., Trinh, Y. T., Zhang, Q., Urbatsch, I. L., & Chang, G. (2009). Structure of P-glycoprotein. Science, 323(5922), 1718–1722. https://doi.org/10.1126/science.1168750
   PubMed Web of Science ®Google Scholar
• Amin, M. L. (2013). P-glycoprotein inhibition for optimal drug delivery. Drug Target Insights, 7(7), 27–34. https://doi.org/10.4137/DTI.S12519
   PubMedGoogle Scholar
• Avram, S., Funar-Timofei, S., Borota, A., Chennamaneni, S. R., Manchala, A. K., & Muresan, S. (2014). Quantitative estimation of pesticide-likeness for agrochemical discovery. Journal of Cheminformatics, 6(1), 42–11. https://doi.org/10.1186/s13321-014-0042-6
   PubMedGoogle Scholar
• Baron, R. (Ed.) (2012)Computational Drug Discovery and Design.Humana Press.
   Google Scholar
• Beale, T. M., Chudzinski, M. G., Sarwar, M. G., & Taylor, M. S. (2013). Halogen bonding in solution: Thermodynamics and applications. Chemical Society Reviews, 42(4), 1667–1680. https://doi.org/10.1039/C2CS35213C
   PubMed Web of Science ®Google Scholar
• Bellamy, W. T. (1996). P-glycoproteins and multidrug resistance. Annual Review of Pharmacology and Toxicology, 36, 161–183. https://doi.org/10.1146/annurev.pa.36.040196.001113
   PubMed Web of Science ®Google Scholar
• Berman, H. M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T. N., Weissig, H., … Bourne, P. E. (2000). The protein data bank. Nucleic Acids Research, 28(1), 235–242. https://doi.org/10.1093/nar/28.1.235
   PubMed Web of Science ®Google Scholar
• Berry, C. C. (2009). Progress in functionalization of magnetic nanoparticles for applications in biomedicine. Journal of Physics D: Applied Physics, 42(22), 224003. https://doi.org/10.1088/0022-3727/42/22/224003
   Web of Science ®Google Scholar
• Cheng, F., Li, W., Zhou, Y., Shen, J., Wu, Z., Liu, G., Lee, P. W., & Tang, Y. (2012). AdmetSAR: A comprehensive source and free tool for assessment of chemical ADMET properties. Journal of Chemical Information and Modeling, 52(11), 3099–3105. https://doi.org/10.1021/ci300367a
   PubMed Web of Science ®Google Scholar
• Chowdhury, S. M., Talukder, S. A., Khan, A. M., Afrin, N., Ali, M. A., Islam, R., Parves, R., Al Mamun, A., Sufian, M. A., Hossain, M. N., Hossain, M. A., & Halim, M. A. (2020). Antiviral peptides as promising therapeutics against SARS-CoV-2. The Journal of Physical Chemistry. B, 124(44), 9785–9792. https://doi.org/10.1021/acs.jpcb.0c05621
   PubMed Web of Science ®Google Scholar
• Compiani, M., & Capriotti, E. (2013). Computational and theoretical methods for protein folding. Biochemistry, 52(48), 8601–8624. https://doi.org/10.1021/bi4001529
   PubMed Web of Science ®Google Scholar
• Dassault Systèmes BIOVIA (2015). Discovery studio modeling environment (p. Release 4.1, San Diego: Dassault Systèmes). p. Release 4.1, San Diego: Dassault Systèmes.
   Google Scholar
• Davidson, B., Goldberg, I., Givant-Horwitz, V., Nesland, J. M., Berner, A., Bryne, M., Risberg, B., Kopolovic, J., Kristensen, G. B., Tropé, C. G., van de Putte, G., & Reich, R. (2002). Caveolin-1 expression in ovarian carcinoma is MDR1 independent. American Journal of Clinical Pathology, 117(2), 225–234. https://doi.org/10.1309/u40r-1bn4-6kj3-bdg3
   PubMed Web of Science ®Google Scholar
• Dickson, C. J., Madej, B. D., Skjevik, Å. A., Betz, R. M., Teigen, K., Gould, I. R., & Walker, R. C. (2014). Lipid14: The amber lipid force field. Journal of Chemical Theory and Computation, 10(2), 865–879. https://doi.org/10.1021/ct4010307
   PubMed Web of Science ®Google Scholar
• Drori, S., Eytan, G. D., & Assaraf, Y. G. (1995). Potentiation of anticancer drug cytotoxicity by multidrug resistance chemosensitizers involves alterations in membrane fluidity leading to increased membrane permeability. European Journal of Biochemistry., 1029(228), 1020–1029.
   Google Scholar
• Edwards, A., Bennett, D., Carswell, E., Cooke, A., & Nimz, O. (2008). Design, structure activity relationships and X-Ray co-crystallography of non-steroidal LXR agonists. Current Medicinal Chemistry, 15(2), 195–209. https://doi.org/10.2174/092986708783330584
   PubMed Web of Science ®Google Scholar
• Ferreira de Freitas, R., & Schapira, M. (2017). A systematic analysis of atomic protein-ligand interactions in the PDB. MedChemComm, 8(10), 1970–1981. https://doi.org/10.1039/c7md00381a
   PubMed Web of Science ®Google Scholar
• Ferry, D. R., & Traunecker, H. (1996). Clinical trials of P-glycoprotein tumours reversal in solid. European Journal of Cancer, 32A(6), 1070–1081.
   Google Scholar
• Fojo, A. T., Ueda, K., Slamon, D. J., Poplack, D. G., Gottesman, M. M., & Pastan, I. (1987). Expression of a multidrug-resistance gene in human tumors and tissues. Proceedings of the National Academy of Sciences of the United States of America, 84(1), 265–269. https://doi.org/10.1073/pnas.84.1.265
   PubMed Web of Science ®Google Scholar
• Fortuna, A., Alves, G., & Falcão, A. (2011). In vitro and in vivo relevance of the P-glycoprotein probe substrates in drug discovery and development: focus on rhodamine 123, digoxin and talinolol. Journal of Bioequivalence & Bioavailability, 01(02), 1–24. https://doi.org/10.4172/jbb.S2-001
   Google Scholar
• Funar-Timofei, S., Borota, A., & Crisan, L. (2017). Combined molecular docking and QSAR study of fused heterocyclic herbicide inhibitors of D1 protein in photosystem II of plants. Molecular Diversity, 21(2), 437–454. https://doi.org/10.1007/s11030-017-9735-x
   PubMed Web of Science ®Google Scholar
• Gandy, M. N., Corral, M. G., Mylne, J. S., & Stubbs, K. A. (2015). An interactive database to explore herbicide physicochemical properties. Organic & Biomolecular Chemistry, 13(20), 5586–5590. https://doi.org/10.1039/c5ob00469a
   PubMed Web of Science ®Google Scholar
• Gibbs, J. B. (2000). Mechanism-based target identification and drug discovery in cancer research. Science (New York, N.Y.), 287(5460), 1969–1973. https://doi.org/10.1126/science.287.5460.1969
   PubMed Web of Science ®Google Scholar
• Gottesman, M. M., & Pastan, I. (1993). Biochemistry of multidrug resistance mediated by the multidrug transporter. Annual Review of Biochemistry, 62, 385–427. https://doi.org/10.1146/annurev.bi.62.070193.002125
   PubMed Web of Science ®Google Scholar
• Hamadache, M., Benkortbi, O., Hanini, S., & Amrane, A. (2018). QSAR modeling in ecotoxicological risk assessment: Application to the prediction of acute contact toxicity of pesticides on bees (Apis mellifera L.). Environmental Science and Pollution Research International, 25(1), 896–907. https://doi.org/10.1007/s11356-017-0498-9
   PubMed Web of Science ®Google Scholar
• Hannongbua, S., Pungpo, P., Limtrakul, J., & Wolschann, P. (1999). Quantitative structure-activity relationships and comparative molecular field analysis of TIBO derivatised HIV-1 reverse transcriptase inhibitors. Journal of Computer-Aided Molecular Design, 13(6), 563–577. https://doi.org/10.1023/A:1008013917905
   PubMed Web of Science ®Google Scholar
• Hollenberg, P. F. (2002). Characteristics and common properties of inhibitors, inducers, and activators of CYP enzymes. Drug Metabolism Reviews, 34(1-2), 17–35. https://doi.org/10.1081/dmr-120001387
   PubMed Web of Science ®Google Scholar
• Irwin, J. J., & Shoichet, B. K. (2005). ZINC-a free database of commercially available compounds for virtual screening. Journal of Chemical Information and Modeling, 45(1), 177–182. (December 2004), https://doi.org/10.1021/ci049714+
   PubMed Web of Science ®Google Scholar
• Islam, M. J., Khan, A. M., Parves, M. R., Hossain, M. N., & Halim, M. A. (2019). Prediction of Deleterious Non-synonymous SNPs of Human STK11 Gene by Combining Algorithms, Molecular Docking, and Molecular Dynamics Simulation. Scientific Reports, 9(1), 1–16. https://doi.org/10.1038/s41598-019-52308-0
   PubMedGoogle Scholar
• Islam, R., Parves, M. R., Paul, A. S., Uddin, N., Rahman, M. S., Mamun, A. A., … Halim, M. A. (2020). A molecular modeling approach to identify effective antiviral phytochemicals against the main protease of SARS-CoV-2. Journal of Biomolecular Structure and Dynamics, 39(9), 3213–3224. https://doi.org/10.1080/07391102.2020.1761883
   Web of Science ®Google Scholar
• Jin, A. Y., Kohn, H., Béguin, C., Andurkar, S. V., Stables, J. P., & Weaver, D. F. (2005). A quantitative structure-activity relationship study for α-substituted acetamido-N-benzylacetamide derivatives - A novel anticonvulsant drug class. Canadian Journal of Chemistry, 83(1), 37–45. https://doi.org/10.1139/v04-160
   Web of Science ®Google Scholar
• Joel, M., Xiangpo, L., & Douglas, M. (2014). Orchestration of enzymatic processing by thiazole/oxazole- modified microcin dehydrogenases. Biochemistry, 53(2), 413–422. https://doi.org/10.1021/jm4004285.QSAR
   PubMed Web of Science ®Google Scholar
• Kamiya, K., Niwa, R., Mitcheson, J. S., & Sanguinetti, M. C. (2006). Molecular determinants of HERG channel block. Molecular Pharmacology, 69(5), 1709–1716. https://doi.org/10.1124/mol.105.020990
   PubMed Web of Science ®Google Scholar
• Kapoor, S. (2013). Maslinic acid and its in vitro anti-neoplastic effects. Natural Product Research, 27(23), 2210–2211. https://doi.org/10.1080/14786419.2013.819506
   PubMed Web of Science ®Google Scholar
• Karacan, M. S., Yakan, C., Yakan, M., Karacan, N., Zharmukhamedov, S. K., Shitov, A., Los, D. A., Klimov, V. V., & Allakhverdiev, S. I. (2012). Quantitative structure-activity relationship analysis of perfluoroiso-propyldinitrobenzene derivatives known as photosystem II electron transfer inhibitors. Biochimica et Biophysica Acta, 1817(8), 1229–1236. https://doi.org/10.1016/j.bbabio.2012.01.010
   PubMed Web of Science ®Google Scholar
• Katritzky, A. R., Lobanov, V. S., & Karelson, M. (1995). QSPR: The correlation and quantitative prediction of chemical and physical properties from structure. Chemical Society Reviews, 24(4), 279–287. https://doi.org/10.1039/cs9952400279
   Web of Science ®Google Scholar
• Kim, Y., & Chen, J. (2018). Molecular structure of human P-glycoprotein in the ATP-bound, outward-facing conformation. Science, 7389, 1–10.
   Google Scholar
• Kim, N., Shin, J. M., & No, K. T. (2014). In silico study on the interaction between p-glycoprotein and its inhibitors at the drug binding pocket. Bulletin of the Korean Chemical Society, 35(8), 2317–2325. https://doi.org/10.5012/bkcs.2014.35.8.2317
   Web of Science ®Google Scholar
• Klebe, G., Abraham, U., & Mietzner, T. (1994). Molecular Similarity Indices in a Comparative Analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. Journal of Medicinal Chemistry, 37(24), 4130–4146. https://doi.org/10.1021/jm00050a010
   PubMed Web of Science ®Google Scholar
• Krieger, E., & Vriend, G. (2015). New ways to boost molecular dynamics simulations. Journal of Computational Chemistry, 36(13), 996–1007. https://doi.org/10.1002/jcc.23899
   PubMed Web of Science ®Google Scholar
• Kuppens, I. E. L. M., Witteveen, E. O., Jewell, R. C., Radema, S. A., Paul, E. M., Mangum, S. G., Beijnen, J. H., Voest, E. E., & Schellens, J. H. M. (2007). A phase I, randomized, open-label, parallel-cohort, dose-finding study of elacridar (GF120918) and oral topotecan in cancer patients. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 13(11), 3276–3285. https://doi.org/10.1158/1078-0432.CCR-06-2414
   PubMed Web of Science ®Google Scholar
• Ling, J., & Kumar, R. (2012). Crosstalk between NFkB and glucocorticoid signaling: A potential target of breast cancer therapy. Cancer Letters, 322(2), 119–126. https://doi.org/10.1016/j.canlet.2012.02.033
   PubMed Web of Science ®Google Scholar
• Liu, T., Lin, Y., Wen, X., Jorissen, R. N., & Gilson, M. K. (2007). BindingDB: A web-accessible database of experimentally determined protein-ligand binding affinities. Nucleic Acids Research, 35(Database), D198–201. https://doi.org/10.1093/nar/gkl999
   PubMed Web of Science ®Google Scholar
• Loo, T. W., & Clarke, D. M. (1997). Identification of residues in the drug-binding site of human P-glycoprotein using a thiol-reactive substrate. The Journal of Biological Chemistry, 272(51), 31945–31948. https://doi.org/10.1074/jbc.272.51.31945
   PubMed Web of Science ®Google Scholar
• Loo, T. W., & Clarke, D. M. (1999). Identification of residues in the drug-binding domain of human P-glycoprotein. Analysis of transmembrane segment 11 by cysteine-scanning mutagenesis and inhibition by dibromobimaneThe Journal of Biological Chemistry, 274(50), 35388–35392. https://doi.org/10.1074/jbc.274.50.35388
   PubMed Web of Science ®Google Scholar
• Loo, T. W., & Clarke, D. M. (2000). Identification of residues within the drug-binding domain of the human multidrug resistance P-glycoprotein by cysteine-scanning mutagenesis and reaction with dibromobimane. The Journal of Biological Chemistry, 275(50), 39272–39278. https://doi.org/10.1074/jbc.M007741200
   PubMed Web of Science ®Google Scholar
• Loo, T. W., & Clarke, D. M. (2001a). Defining the drug-binding site in the human multidrug resistance p-glycoprotein using a methanethiosulfonate analog of verapamil, MTS-verapamil. The Journal of Biological Chemistry, 276(18), 14972–14979. https://doi.org/10.1074/jbc.M100407200
   PubMed Web of Science ®Google Scholar
• Loo, T. W., & Clarke, D. M. (2001b). Determining the dimensions of the drug-binding domain of human P-glycoprotein using thiol cross-linking compounds as molecular rulers. The Journal of Biological Chemistry, 276(40), 36877–36880. https://doi.org/10.1074/jbc.C100467200
   PubMed Web of Science ®Google Scholar
• Loo, T. W., & Clarke, D. M. (2017). Attachment of a 'molecular spring' restores drug-stimulated ATPase activity to P-glycoprotein lacking both Q loop glutamines . Biochemical and Biophysical Research Communications, 483(1), 366–370. https://doi.org/10.1016/j.bbrc.2016.12.137
   PubMed Web of Science ®Google Scholar
• Malinowski, E. R. (1991). Factor analysis in chemistry (2nd ed., Vol. 21). Wiley. https://doi.org/10.11329/jjss1970.21.147
   Google Scholar
• Mitsutake, K. I., Iwamura, H., Shimizu, R., & Fujita, T. (1986). Quantitative structure-activity relationship of photosystem II inhibitors in chloroplasts and its link to herbicidal action. Journal of Agricultural and Food Chemistry, 34(4), 725–732. https://doi.org/10.1021/jf00070a034
   Web of Science ®Google Scholar
• Papaneophytou, C. P., Grigoroudis, A. I., McInnes, C., & Kontopidis, G. (2014). Quantification of the effects of ionic strength, viscosity, and hydrophobicity on protein-ligand binding affinity. ACS Medicinal Chemistry Letters, 5(8), 931–936. https://doi.org/10.1021/ml500204e
   PubMed Web of Science ®Google Scholar
• Paul, A. S., Islam, R., Parves, M. R., Mamun, A., Al, Shahriar, I., Hossain, M. I., … Halim, M. A. (2020). Cysteine focused covalent inhibitors against the main protease of SARS-CoV-2. Journal of Biomolecular Structure and Dynamics, 1–20. https://doi.org/10.1080/07391102.2020.1831610
   Google Scholar
• Pleban, K., Kopp, S., Csaszar, E., Peer, M., Hrebicek, T., Rizzi, A., Ecker, G. F., & Chiba, P. (2005). P-glycoprotein substrate binding domains are located at the transmembrane domain/transmembrane domain interfaces: A combined photoaffinity labeling-protein homology modeling approach. Molecular Pharmacology, 67(2), 365–374. https://doi.org/10.1124/mol.104.006973
   PubMed Web of Science ®Google Scholar
• Richard, M., Gutiérrez, A. V., Viljoen, A. J., Ghigo, E., Blaise, M., & Kremer, L. (2018). Mechanistic and structural insights into the unique TetR-dependent regulation of a drug efflux pump in Mycobacterium abscessus. Frontiers in Microbiology, 9(APR), 649–618. https://doi.org/10.3389/fmicb.2018.00649
   PubMedGoogle Scholar
• Robert, J., & Jarry, C. (2003). Multidrug resistance reversal agents. Journal of Medicinal Chemistry, 46(23), 4805–4817. https://doi.org/10.1021/jm030183a
   PubMed Web of Science ®Google Scholar
• Rustgi, V. (1990). Book review. Gastrointestinal Endoscopy, 36(3), 328. https://doi.org/10.1016/S0016-5107(90)71056-5
   Google Scholar
• Sandler, A., Gordon, M., De Alwis, D. P., Pouliquen, I., Green, L., Marder, P., Chaudhary, A., Fife, K., Battiato, L., Sweeney, C., Jordan, C., Burgess, M., & Slapak, C. A. (2004). A phase I trial of a potent P-glycoprotein inhibitor, zosuquidar trihydrochloride (LY335979), administered intravenously in combination with doxorubicin in patients with advanced malignancy. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 10(10), 3265–3272. https://doi.org/10.1158/1078-0432.CCR-03-0644
   PubMed Web of Science ®Google Scholar
• Sanguinetti, M. C., & Tristani-Firouzi, M. (2006). hERG potassium channels and cardiac arrhythmia. Nature, 440(7083), 463–469. https://doi.org/10.1038/nature04710
   PubMed Web of Science ®Google Scholar
• Sarwar, M. G., Ajami, D., Theodorakopoulos, G., Petsalakis, I. D., & Rebek, J. (2013). Amplified halogen bonding in a small space. Journal of the American Chemical Society, 135(37), 13672–13675. https://doi.org/10.1021/ja407815t
   PubMed Web of Science ®Google Scholar
• Sarwar, M. G., Dragisic, B., Salsberg, L. J., Gouliaras, C., & Taylor, M. S. (2010). Thermodynamics of halogen bonding in solution: Substituent, structural, and solvent effects. Journal of the American Chemical Society, 132(5), 1646–1653. https://doi.org/10.1021/ja9086352
   PubMed Web of Science ®Google Scholar
• Shapiro, A. B., & Ling, V. (1997). Effect of quercetin in Hoechst 33342 transport by purified and reconstituted P-glycoprotein. Biochemical Pharmacology, 53(4), 587–596. https://doi.org/10.1016/S0006-2952(96)00826-X
   PubMed Web of Science ®Google Scholar
• Sharom, F. J. (2011). The P-glycoprotein multidrug transporter . Essays in Biochemistry, 50(1), 161–178. https://doi.org/10.1042/bse0500161
   PubMed Web of Science ®Google Scholar
• Shityakov, S., & Förster, C. (2014). In silico structure-based screening of versatile P-glycoprotein inhibitors using polynomial empirical scoring functions. Advances and Applications in Bioinformatics and Chemistry, 7(1), 1–9. https://doi.org/10.2147/AABC.S56046
   Google Scholar
• Simmerling, C. (2015). ff 14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff 99SB, https://doi.org/10.1021/acs.jctc.5b00255
   Google Scholar
• Sneha, P., & Doss, C. G. P. (2016). Gliptins in managing diabetes - Reviewing computational strategy. Life Sciences, 166, 108–120. https://doi.org/10.1016/j.lfs.2016.10.009
   PubMed Web of Science ®Google Scholar
• Soma, C. E., Dubernet, C., Bentolila, D., Benita, S., & Couvreur, P. (2000). Reversion of multidrug resistance by co-encapsulation of doxorubicin and cyclosporin A in polyalkylcyanoacrylate nanoparticles. Biomaterials, 21(1), 1–7. https://doi.org/10.1016/S0142-9612(99)00125-8
   PubMed Web of Science ®Google Scholar
• Speck-Planche, A., Kleandrova, V. V., & Rojas-Vargas, J. A. (2011). QSAR model toward the rational design of new agrochemical fungicides with a defined resistance risk using substructural descriptors. Molecular Diversity, 15(4), 901–909. https://doi.org/10.1007/s11030-011-9320-7
   PubMed Web of Science ®Google Scholar
• Srivalli, K. M. R., & Lakshmi, P. K. (2012). Overview of P-glycoprotein inhibitors: a rational outlook. Brazilian Journal of Pharmaceutical Sciences, 48(3), 353–367. https://doi.org/10.1590/S1984-82502012000300002
   Web of Science ®Google Scholar
• Srivastava, V., Sinha, D., Tiwari, A. K., Sharma, H., Bala Sharma, R., Singh, V. K., & Mishra, A. K. (2010). Quantitative structure-activity relationship analysis of 4(3H)-quinazolone derivatives as tyrosine kinase inhibitors by multiple linear regression. Cancer Biotherapy & Radiopharmaceuticals, 25(5), 559–562. https://doi.org/10.1089/cbr.2010.0791
   PubMed Web of Science ®Google Scholar
• Szakács, G., Paterson, J. K., Ludwig, J. A., Booth-Genthe, C., & Gottesman, M. M. (2006). Targeting multidrug resistance in cancer. Nature Reviews. Drug Discovery, 5(3), 219–234. https://doi.org/10.1038/nrd1984
   PubMed Web of Science ®Google Scholar
• Tiwari, A. K., Ojha, H., Kaul, A., Dutta, A., Srivastava, P., Shukla, G., Srivastava, R., & Mishra, A. K. (2009). Quantitative structure-property relationship (correlation analysis) of phosphonic acid-based chelates in design of MRI contrast agent. Chemical Biology & Drug Design, 74(1), 87–91. https://doi.org/10.1111/j.1747-0285.2009.00826.x
   PubMed Web of Science ®Google Scholar
• Tobias, R. D., Beebe, K. R., Pell, R. J., & Seasholtz, M. B. (1999). Chemometrics: A practical guide. Technometrics, 41(4), 375–376. https://doi.org/10.2307/1271366
   Google Scholar
• Trott, O., & Olson, A. (2010). NIH Public Access. Journal of Computational Chemistry, 31(2), 455–461. https://doi.org/10.1002/jcc.21334.AutoDock
   PubMed Web of Science ®Google Scholar
• Urbatsch, I. L., Gimi, K., Wilke-Mounts, S., & Senior, A. E. (2000). Investigation of the role of glutamine-471 and glutamine-1114 in the two catalytic sites of P-glycoprotein. Biochemistry, 39(39), 11921–11927. https://doi.org/10.1021/bi001220s
   PubMed Web of Science ®Google Scholar
• Varma, M. V. S., Ashokraj, Y., Dey, C. S., & Panchagnula, R. (2003). P-glycoprotein inhibitors and their screening: A perspective from bioavailability enhancement. Pharmacological Research, 48(4), 347–359. https://doi.org/10.1016/S1043-6618(03)00158-0
   PubMed Web of Science ®Google Scholar
• Venko, K., Župerl, Š., & Novič, M. (2014). Prediction of antiprion activity of therapeutic agents with structure-activity models. Molecular Diversity, 18(1), 133–148. https://doi.org/10.1007/s11030-013-9477-3
   PubMed Web of Science ®Google Scholar
• Verma, J., Khedkar, V., & Coutinho, E. (2010). 3D-QSAR in drug design-a review. Current Topics in Medicinal Chemistry, 10(1), 95–115. https://doi.org/10.2174/156802610790232260
   PubMed Web of Science ®Google Scholar
• Wang, S., Zhao, Y., Zhang, G., Lv, Y., Zhang, N., & Gong, P. (2011). Design, synthesis and biological evaluation of novel 4-thiazolidinones containing indolin-2-one moiety as potential antitumor agent. European Journal of Medicinal Chemistry, 46(8), 3509–3518. https://doi.org/10.1016/j.ejmech.2011.05.017
   PubMed Web of Science ®Google Scholar
• Yadav, D. K., & Khan, F. (2013). QSAR, docking and ADMET studies of camptothecin derivatives as inhibitors of DNA. Journal of Chemometrics, 27(1-2), 21–33. https://doi.org/10.1002/cem.2488
   Web of Science ®Google Scholar
• Yuan, H., Tai, W., Hu, S., Liu, H., Zhang, Y., Yao, S., Ran, T., Lu, S., Ke, Z., Xiong, X., Xu, J., Chen, Y., & Lu, T. (2013). Fragment-based strategy for structural optimization in combination with 3D-QSAR. Journal of Computer-Aided Molecular Design, 27(10), 897–915. https://doi.org/10.1007/s10822-013-9687-x
   PubMed Web of Science ®Google Scholar
• Zolnerciks, J. K., Akkaya, B. G., Snippe, M., Chiba, P., Seelig, A., & Linton, K. J. (2014). The Q loops of the human multidrug resistance transporter ABCB1 are necessary to couple drug binding to the ATP catalytic cycle. FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology, 28(10), 4335–4346. https://doi.org/10.1096/fj.13-245639
   PubMed Web of Science ®Google Scholar
• Zolnerciks, J. K., Wooding, C., & Linton, K. J. (2007). Evidence for a Sav1866-like architecture for the human multidrug transporter P-glycoprotein. FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology, 21(14), 3937–3948. https://doi.org/10.1096/fj.07-8610com
   PubMed Web of Science ®Google Scholar